Matthew A. Cerny

875 total citations
25 papers, 655 citations indexed

About

Matthew A. Cerny is a scholar working on Pharmacology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Matthew A. Cerny has authored 25 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 10 papers in Oncology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Matthew A. Cerny's work include Pharmacogenetics and Drug Metabolism (15 papers), Drug Transport and Resistance Mechanisms (8 papers) and Hormonal Regulation and Hypertension (6 papers). Matthew A. Cerny is often cited by papers focused on Pharmacogenetics and Drug Metabolism (15 papers), Drug Transport and Resistance Mechanisms (8 papers) and Hormonal Regulation and Hypertension (6 papers). Matthew A. Cerny collaborates with scholars based in United States, Finland and Germany. Matthew A. Cerny's co-authors include Robert P. Hanzlik, Xiaodong Zhang, Travis T. Denton, Jason K. Yano, Eric F. Johnson, John R. Cashman, R. Scott Obach, Douglas K. Spracklin, Heather Eng and Kosea S. Frederick and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Methods in enzymology on CD-ROM/Methods in enzymology.

In The Last Decade

Matthew A. Cerny

25 papers receiving 639 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew A. Cerny United States	14	349	218	170	99	91	25	655
Jairam Palamanda United States	19	339 1.0×	223 1.0×	252 1.5×	94 0.9×	108 1.2×	35	968
Hiroshi Komura Japan	17	286 0.8×	273 1.3×	245 1.4×	100 1.0×	78 0.9×	40	817
Michael A. Mohutsky United States	18	437 1.3×	210 1.0×	164 1.0×	93 0.9×	40 0.4×	34	716
Michael Schrag United States	14	423 1.2×	270 1.2×	219 1.3×	139 1.4×	71 0.8×	20	779
George Tonn United States	17	256 0.7×	242 1.1×	332 2.0×	104 1.1×	178 2.0×	31	939
Jackie C. Bloomer United Kingdom	13	268 0.8×	180 0.8×	261 1.5×	54 0.5×	36 0.4×	20	751
Kenneth J. Ruterbories United States	14	438 1.3×	290 1.3×	211 1.2×	78 0.8×	77 0.8×	37	990
Andrew P. Blanchard United States	6	351 1.0×	144 0.7×	140 0.8×	99 1.0×	41 0.5×	8	535
Paul Toren United States	11	284 0.8×	193 0.9×	206 1.2×	47 0.5×	52 0.6×	22	661
Xavier Boulenc France	15	336 1.0×	303 1.4×	198 1.2×	59 0.6×	36 0.4×	19	814

Countries citing papers authored by Matthew A. Cerny

Since Specialization

Citations

This map shows the geographic impact of Matthew A. Cerny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew A. Cerny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew A. Cerny more than expected).

Fields of papers citing papers by Matthew A. Cerny

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew A. Cerny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew A. Cerny. The network helps show where Matthew A. Cerny may publish in the future.

Co-authorship network of co-authors of Matthew A. Cerny

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew A. Cerny. A scholar is included among the top collaborators of Matthew A. Cerny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew A. Cerny. Matthew A. Cerny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Weldon, Steven M., Derek A. Cogan, Matthew A. Cerny, et al.. (2025). Pharmacodynamic effects of highly selective aldosterone synthase inhibitor vicadrostat in cynomolgus monkeys: Contrasting effects of once versus twice daily dosing. Journal of Pharmacology and Experimental Therapeutics. 392(8). 103649–103649. 1 indexed citations

Bauman, Jonathan, Angela C. Doran, Brian Hee, et al.. (2024). The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Ritlecitinib, a Janus Kinase 3 and Tyrosine-Protein Kinase Family Inhibitor, in Humans. Drug Metabolism and Disposition. 52(10). 1124–1136. 7 indexed citations

Cerny, Matthew A., Douglas K. Spracklin, & R. Scott Obach. (2023). Human Absorption, Distribution, Metabolism, and Excretion Studies: Origins, Innovations, and Importance. Drug Metabolism and Disposition. 51(6). 647–656. 12 indexed citations

Cerny, Matthew A., et al.. (2023). High-throughput cytochrome P450 loss and metabolic intermediate complex assays to aid in designing out of CYP3A inactivation. Methods in enzymology on CD-ROM/Methods in enzymology. 690. 341–368. 3 indexed citations

Rodrigues, David, Mark Niosi, Heather Eng, et al.. (2023). Attempting to Unmask the Inhibition of Sulfotransferase 1E1 in 17α‐Ethinyl Estradiol Drug Interactions. The Journal of Clinical Pharmacology. 63(8). 875–879. 2 indexed citations

Tseng, Elaine, Heather Eng, Jian Lin, et al.. (2021). Static and Dynamic Projections of Drug-Drug Interactions Caused by Cytochrome P450 3A Time-Dependent Inhibitors Measured in Human Liver Microsomes and Hepatocytes. Drug Metabolism and Disposition. 49(10). 947–960. 27 indexed citations

Eng, Heather, Elaine Tseng, Matthew A. Cerny, Theunis C. Goosen, & R. Scott Obach. (2021). Cytochrome P450 3A Time-Dependent Inhibition Assays Are Too Sensitive for Identification of Drugs Causing Clinically Significant Drug-Drug Interactions: A Comparison of Human Liver Microsomes and Hepatocytes and Definition of Boundaries for Inactivation Rate Constants. Drug Metabolism and Disposition. 49(6). 442–450. 21 indexed citations

Cerny, Matthew A., Amit S. Kalgutkar, R. Scott Obach, et al.. (2020). Effective Application of Metabolite Profiling in Drug Design and Discovery. Journal of Medicinal Chemistry. 63(12). 6387–6406. 33 indexed citations

Ramsden, Diane, et al.. (2018). Identification and Characterization of a Selective Human Carbonyl Reductase 1 Substrate. Drug Metabolism and Disposition. 46(10). 1434–1440. 8 indexed citations

10.

Thakare, Rhishikesh, Hongying Gao, Rachel E. Kosa, et al.. (2017). Leveraging of Rifampicin-Dosed Cynomolgus Monkeys to Identify Bile Acid 3-O-Sulfate Conjugates as Potential Novel Biomarkers for Organic Anion-Transporting Polypeptides. Drug Metabolism and Disposition. 45(7). 721–733. 38 indexed citations

11.

Cerny, Matthew A.. (2016). Prevalence of Non–Cytochrome P450–Mediated Metabolism in Food and Drug Administration–Approved Oral and Intravenous Drugs: 2006–2015. Drug Metabolism and Disposition. 44(8). 1246–1252. 108 indexed citations

12.

Weldon, Steven M., Matthew A. Cerny, Derek A. Cogan, et al.. (2016). Selectivity of BI 689648, a Novel, Highly Selective Aldosterone Synthase Inhibitor: Comparison with FAD286 and LCI699 in Nonhuman Primates. Journal of Pharmacology and Experimental Therapeutics. 359(1). 142–150. 23 indexed citations

13.

Sadeque, Abu Jafar Md., et al.. (2016). Identification of Human Sulfotransferases Involved in Lorcaserin N-Sulfamate Formation. Drug Metabolism and Disposition. 44(4). 570–575. 5 indexed citations

14.

Cerny, Matthew A., et al.. (2015). Development of CYP11B1 and CYP11B2 assays utilizing homogenates of adrenal glands: Utility of monkey as a surrogate for human. The Journal of Steroid Biochemistry and Molecular Biology. 154. 197–205. 13 indexed citations

15.

Hutzler, J. Matthew, et al.. (2014). Cynomolgus Monkey as a Surrogate for Human Aldehyde Oxidase Metabolism of the EGFR Inhibitor BIBX1382. Drug Metabolism and Disposition. 42(10). 1751–1760. 22 indexed citations

16.

Fryer, Ryan M., Lori Patnaude, Donna Skow, et al.. (2014). G Protein–Coupled Bile Acid Receptor 1 Stimulation Mediates Arterial Vasodilation through a KCa1.1 (BKCa)–Dependent Mechanism. Journal of Pharmacology and Experimental Therapeutics. 348(3). 421–431. 39 indexed citations

17.

Cerny, Matthew A.. (2013). Progress Towards Clinically Useful Aldosterone Synthase Inhibitors. Current Topics in Medicinal Chemistry. 13(12). 1385–1401. 27 indexed citations

18.

Sadeque, Abu Jafar Md., et al.. (2012). Identification of Human UDP-Glucuronosyltransferases Involved in N-Carbamoyl Glucuronidation of Lorcaserin. Drug Metabolism and Disposition. 40(4). 772–778. 21 indexed citations

19.

Cerny, Matthew A. & Robert P. Hanzlik. (2005). Cyclopropylamine inactivation of cytochromes P450: Role of metabolic intermediate complexes. Archives of Biochemistry and Biophysics. 436(2). 265–275. 31 indexed citations

20.

Lucas, Laura H., Matthew A. Cerny, Yakov M. Koen, Robert P. Hanzlik, & Cynthia K. Larive. (2004). 1H high-resolution magic-angle spinning (HR-MAS) NMR analysis of ligand density on resins using a resin internal standard. Analytical and Bioanalytical Chemistry. 380(4). 627–631. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact